Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery vs Bromocriptine for Knosp Grade 0-2 Prolactinoma
NCT06556186Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2024
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
01
Overview
Randomised, open-label trial of bromocriptine in prolactinoma (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Pituitary hormone levels at 12 months and Pituitary MRI at 12 months. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
bromocriptine
03
Conditions
prolactinoma
Beyond the preview
Go deeper on NCT06556186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06556186.